ECM Therapeutics, Inc.

Restoring health and functional tissues with extracellular matrix-based signaling molecules

General Information
Company Name
ECM Therapeutics, Inc.
Founded Year
2018
Location (Offices)
Warrendale, United States +1
Founders / Decision Makers
Number of Employees
8
Industries
Biotechnology, Health and Wellness
Funding Stage
Series Unknown
Social Media

ECM Therapeutics, Inc. - Company Profile

ECM Therapeutics, Inc. is a biotechnology startup founded in 2018 with the goal of advancing regenerative medicine. The company focuses on developing natural biomaterials that restore the body's natural template to treat diseases and injuries. Their ECM scaffolds, which have been used in over 10 million human patients, have received FDA clearance for repairing musculoskeletal tissues, cardiovascular structures, and non-healing skin wounds.

One of their key innovations is the patented ECM hydrogel technology, which enables less invasive applications in multiple disease areas. Their first clinical product, EsophaGel, is designed to treat Barrett’s esophagus, a precancerous condition currently lacking effective therapy. This signifies the potential for broader applications of their technology platform in addressing unmet medical needs. The company's last investment was a $15.92M Venture Round investment on 18 June 2019, reflecting investor confidence in the company's vision and capabilities.

Overall, ECM Therapeutics, Inc. holds promise in driving advancements in regenerative medicine with its innovative approach and strong focus on product development and commercialization. With its successful track record and ongoing technological advancements, the company has positioned itself as a key player in the biotechnology industry, aiming to make a significant impact in addressing various medical challenges.

Taxonomy: regenerative medicine, biomaterials, extracellular matrix (ECM), tissue engineering, FDA clearance, clinical products, hydrogel technology, therapeutic products, diagnostic products, cell attachment, cell migration, tissue restoration, injury treatment, Warrendale, Pennsylvania

Funding Rounds & Investors of ECM Therapeutics, Inc. (2)

View All
Funding Stage Amount No. Investors Investors Date
Venture Round $15.92M - 18 Jun 2019
Venture Round $21.04M - 18 Jun 2018

Latest News of ECM Therapeutics, Inc.

View All

No recent news or press coverage available for ECM Therapeutics, Inc..

Similar Companies to ECM Therapeutics, Inc.

View All
Engitix Therapeutics - Similar company to ECM Therapeutics, Inc.
Engitix Therapeutics Rethinking drug discovery for fibrosis and cancer
Symic Bio - Similar company to ECM Therapeutics, Inc.
Symic Bio A new category of therapeutics based on extracellular matrix biology
Miltenyi Biotec - Similar company to ECM Therapeutics, Inc.
Miltenyi Biotec Empowering discovery. Advancing therapy.
Fluicell - Similar company to ECM Therapeutics, Inc.
Fluicell Making tissue therapeutics possible to defeat serious disease
Pathfinder Cell Therapy - Similar company to ECM Therapeutics, Inc.
Pathfinder Cell Therapy Innovation in cell-based therapy for regenerative healing across diabetes, renal disease, myocardial infarction, and beyond.